Literature DB >> 31948898

An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients.

Ayse Kurtulmus1, Ahmet Elbay2, Fatma Busra Parlakkaya3, Tezer Kilicarslan3, Mehmet Hakan Ozdemir2, Ismet Kirpinar3.   

Abstract

INTRODUCTION: A large number of studies using different neuroimaging methods showed various structural changes both in patients and their unaffected first-degree relatives (FDRs) over the past years. Optical coherence tomography (OCT) is a relatively new, non-invasive imaging method used to obtain high-resolution cross-sectional images of the retina. A growing body of evidence reports thinning of retinal layers in patients with schizophrenia which is considered as a proxy for CNS alterations. We hypothesized that retinal layer changes would be observed in FDRs, in parallel with those seen in patients, as a potential endophenotype candidate.
METHODS: Thirty-eight schizophrenia patients, 38 FDRs of schizophrenia and 38 age and gender-matched healthy subjects with no family history (HCs) were recruited to this study. OCT measurements were performed and peripapillary retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL) and macular thicknesses were measured.
RESULTS: The groups did not differ on RNFL, macular or GCL thickness. However, IPL thickness was significantly lower in both patients and FDRs than HCs (p = .025 and p = .041, respectively). The difference between groups remained significant after controlling for confounders such as age, gender, smoking status, comorbid medical diseases and BMI (p = .016 patients vs HCs and p = .014 FDRs vs HCs).
CONCLUSION: Our findings suggest that IPL thinning may hold promise as a useful endophenotype for genetic and early detection studies. The evaluation of this area could provide an important avenue for elucidating some of the neurodevelopmental aberrations in the disorder.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endophenotype; OCT; Retinal thinning; Schizophrenia

Mesh:

Year:  2020        PMID: 31948898     DOI: 10.1016/j.schres.2019.12.034

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

Review 1.  Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis.

Authors:  Hiroshi Komatsu; Goh Onoguchi; Stefan Jerotic; Nobuhisa Kanahara; Yoshihisa Kakuto; Takashi Ono; Shunichi Funakoshi; Takeshi Yabana; Toru Nakazawa; Hiroaki Tomita
Journal:  Mol Psychiatry       Date:  2022-05-02       Impact factor: 15.992

2.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Neuroretinal Biomarkers for Schizophrenia Spectrum Disorders.

Authors:  Samuel Asanad; Hugh O'Neill; Hampton Addis; Shuo Chen; Jingtao Wang; Eric Goldwaser; Peter Kochunov; L Elliot Hong; Osamah J Saeedi
Journal:  Transl Vis Sci Technol       Date:  2021-04-01       Impact factor: 3.283

Review 4.  Literature Review on Artificial Intelligence Methods for Glaucoma Screening, Segmentation, and Classification.

Authors:  José Camara; Alexandre Neto; Ivan Miguel Pires; María Vanessa Villasana; Eftim Zdravevski; António Cunha
Journal:  J Imaging       Date:  2022-01-20

5.  Early-Stage Repetitive Transcranial Magnetic Stimulation Altered Posterior-Anterior Cerebrum Effective Connectivity in Methylazoxymethanol Acetate Rats.

Authors:  Huiling Guo; Yao Xiao; Dandan Sun; Jingyu Yang; Jie Wang; Huaning Wang; Chunyu Pan; Chao Li; Pengfei Zhao; Yanbo Zhang; Jinfeng Wu; Xizhe Zhang; Fei Wang
Journal:  Front Neurosci       Date:  2021-05-21       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.